FDA Inspection 1096743 — Mary Kay, Inc
The FDA completed an inspection of Mary Kay, Inc on Jul 19, 2019 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 19, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dallas, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1220 | 21 CFR 211.67(b)(3) | Cleaning SOPs/instructions |
| 1790 | 21 CFR 211.80(b) | Handling and Storage to Prevent Contamination |
| 1797 | 21 CFR 211.82(a) | Examination on receipt, before acceptance |